You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

CLINICAL TRIALS PROFILE FOR SORBITOL-MANNITOL


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for SORBITOL-MANNITOL

Trial ID Title Status Sponsor Phase Start Date Summary
NCT03636971 ↗ Gait Analysis Following Knee Viscosupplementation Completed Brigitte Jolles, MD Phase 2/Phase 3 2013-05-01 This is a pilot, double-blind, randomised trial that investigates which gait parameters are more sensitive following a single bolus injection of hyaluronic acid with mannitol, hyaluronic acid with sorbitol, or saline placebo for knee osteoarthritis. Outcome measures are gait analysis through a inertial sensors (Physilog), Knee Society Score (KSS), University of California Los Angeles (UCLA) activity-scale and EuroQol 5Dimensions. Follow-up will be of 4 weeks.
NCT03747679 ↗ Palatability (Taste) of Oral Formulations of Bosutinib Completed Pfizer Phase 1 2018-11-22 Healthy Adult Volunteer Taste Study of Oral Formulations of Bosutinib for Pediatric Use. This will be a single-blind, randomized, multiple-period (dosing over 4 days) study in healthy male and/or female participants. Approximately 8 participants will assess the sensory attributes of different powder for oral suspension (POS) formulations.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for SORBITOL-MANNITOL

Condition Name

Condition Name for SORBITOL-MANNITOL
Intervention Trials
Gait 1
Injection 1
Knee Osteoarthritis 1
CML 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for SORBITOL-MANNITOL
Intervention Trials
Osteoarthritis, Knee 1
Osteoarthritis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for SORBITOL-MANNITOL

Trials by Country

Trials by Country for SORBITOL-MANNITOL
Location Trials
Belgium 1
Switzerland 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for SORBITOL-MANNITOL

Clinical Trial Phase

Clinical Trial Phase for SORBITOL-MANNITOL
Clinical Trial Phase Trials
Phase 2/Phase 3 1
Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for SORBITOL-MANNITOL
Clinical Trial Phase Trials
Completed 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for SORBITOL-MANNITOL

Sponsor Name

Sponsor Name for SORBITOL-MANNITOL
Sponsor Trials
Brigitte Jolles, MD 1
Pfizer 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for SORBITOL-MANNITOL
Sponsor Trials
Other 1
Industry 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.